Finally, we have shown that TAZ and YAP can be pharmacologically inhibited by verteporfin in sarcomas, proof of principle that TAZ and YAP represent therapeutic targets in a number of sarcomas (Figure 6). This evidence concerns the gene YAP1 and sarcoma.